Facilitated by
- Sabra S. Custer, DNP, MS, FNP-BC, AAHIVS
Associate Professor
College of Nursing
University of South Carolina - Stewart Roberts
Peer Adherence Coach, Tandem Health
May 29, 2024
Presentation
Slides
- Summarize the pharmacologic action and effectiveness of long-acting injectable (LAI) cabotegravir/rilpivirine (CAB/RPV) for HIV treatment
- List at least three important patient criteria to consider when assessing appropriateness of HIV treatment with LAI CAB/RPV
- Explain the administration process, dosing schedule, and monitoring schedule for LAI CAB/RPV
- List positive and negative patient experiences with using LAI CAB/RPV for HIV treatment
Other Trainings
- Webinar: Lest We Forget – World AIDS Remembrance Day
- Webinar: HIV Screening and Linkage to Care Initiatives: An Update from the Midlands of South Carolina
- Webinar: Bridging the Gap: Effective Linkage to Care for New HIV Providers
- Webinar: Delivering HIV Test Results
- Webinar: Sexual History Taking and Status Neutral Approach
